Clinical Trial Update: Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection

View source ↗

Summary

Expanded access for sulopenem etzadroxil/probenecid in complicated urinary tract infection and acute pyelonephritis is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Sulopenem etzadroxil/probenecid (sulopenem etzadroxil/probenecid)

Snippet

Sponsor: Iterum Therapeutics, International Limited | Conditions: Complicated Urinary Tract Infection, Acute Pyelonephritis | Status: NO_LONGER_AVAILABLE